Search
|
Browse by Day
|
Author Index
Author Index: O
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
O'Donoghue, A.
INFLUENCES ON PHYSICIANS' ASSESSMENTS AND DECISIONS REGARDING PRESCRIPTION DRUG EFFECTIVENESS
O'Neill, S.
A NOVEL USE OF NATURAL LANGUAGE PROCESSING TO ANALYZE MEDICAL DEVICE ADVERSE EVENT REPORTS
O'Reilly, D. J.
THE APPLICATION OF POLICY DISEASE MODELS TO HEALTH CARE DECISION-MAKING IN DIABETES: FINDINGS FROM AN EVALUATION OF FOUR STRATEGIES FOR THE MANAGEMENT OF TYPE 2 DIABETES USING THE ONTARIO DIABETES ECONOMIC MODEL (ODEM)
USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC) TO THE EQ-5D
Odegaard, F.
MODELLING A PAY-FOR-PERFORMANCE RISK SHARING AGREEMENT
Oh, P.
BRIDGING MULTICRITERIA DECISION ANALYSIS (MCDA) WITH HEALTH TECHNOLOGY ASSESSMENT (HTA) FOR POLICY AND CLINICAL DECISIONMAKING: CASE STUDIES IN CANADA AND SOUTH AFRICA
Ohata, J.
ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
Ohta, S.
DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
Oja-Tebbe, N.
USING TEST ATTRIBUTES TO DESCRIBE PATIENT PREFERENCES FOR COLON CANCER SCREENING TESTS
Olkin, I.
META-ANALYSIS: STATISTICAL METHODS FOR COMBINING THE RESULTS OF INDEPENDENT STUDIES
Ollendorf, D. A.
A COST-EFFECTIVENESS ANALYSIS OF THERAPEUTIC OPTIONS FOR LOW RISK PROSTATE CANCER
Olsen, J. A.
ORPHAN DRUGS: DOES SOCIETY VALUE RARITY?
Onetto, N.
PHARMCOGENETIC TESTING AND EVIDENCE-BASED DECISION-MAKING IN ONTARIO: THE APPLICATION OF ONTARIO'S DECISION DETERMINANTS FRAMEWORK TO THE EVALUATION OF PHARMACOGENETIC TESTS
Ornelas, J.
THE COST-EFFECTIVENESS OF GENETIC SCREENING IN NEONATAL DIABETES
Orrbine, E.
DIAGNOSTIC ERRORS ARE COMMON CAUSES OF ADVERSE EVENTS IN HOSPITALIZED CANADIAN CHILDREN
Ortendahl, J. D.
MODELING HISTORICAL TRENDS IN CERVICAL CANCER USING A MULTI-COHORT MODEL
Otero, Sr., J.
DIAGNOSTIC ERRORS OF METHODOLOGIC NATURE
Ouimet, M.
SHARED DECISION MAKING BEHAVIOURS IN FAMILY MEDICINE RESIDENTS
Oviedo-Joekes, E.
THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
Owens, D. K.
CARE COORDINATION: WHAT WORKS? MAKING SENSE OF A VAST LITERATURE VIA A SYSTEMATIC REVIEW OF REVIEWS
COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
COST EFFECTIVENESS OF STOCKPILING PROTECTIVE FACEWEAR FOR AN INFLUENZA PANDEMIC
COST EFFECTIVENESS OF SCREENING FOR ACUTE HIV AND HCV INFECTION IN INJECTION DRUG USERS
Owsley, C.
COST EFFECTIVENESS OF EARLIER CATARACT SURGERY TO PREVENT MOTOR VEHICLE COLLISIONS
Ozaltin, O.
OPTIMAL STRAIN SELECTION FOR THE ANNUAL INFLUENZA VACCINE UNDER THE CLOSEST ANTIGENIC DISTANCE IMMUNITY MODEL
Ozanne, E. M.
BREASTHEALTHDECISIONS.ORG: RISK ASSESSMENT AND DECISION SUPPORT FOR BREAST CANCER PREVENTION
CONCURRENT ORAL SESSION B: RISK PERCEPTION
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z